Medicines in Development

Each patient battling a disease or managing a chronic condition lives in the hope that tomorrow will bring a new medicine that delivers better health. America’s biopharmaceutical research companies share the same goal, constantly developing new medicines that can prevent diseases, improve patients’ health, and save lives. 

Since 2000, more than 500 new medicines have been approved by the FDA, helping patients live longer, healthier lives. Medications are transforming many cancers into treatable conditions, reducing the impact of cardiovascular disease, offering new options for patients with hard-to-treat diseases like Alzheimer’s and Parkinson’s, and fighting even the rarest conditions. Explore the medicines in development for a wide range of diseases below. 

Report

Medicines in Development for Alzheimer's Disease 2017 Report

America’s biopharmaceutical research companies are investigating or developing 85 medicines for Alzheimer's.

Report

Medicines in Development for Arthritis 2014 Report

America’s biopharmaceutical research companies are developing 92 innovative new medicines to help the millions of Americans affected by arthritis.

Report

Medicines in Development for Asthma 2012 Report

America’s biopharmaceutical research companies are working on 74 medicines to treat asthma.

Report

Medicines in Development for Autoimmune Diseases 2016 Report

America’s biopharmaceutical research companies are investigating or developing 80 medicines for autoimmune diseases.

Report

Medicines in Development for Biologics 2013 Report

America’s biopharmaceutical research companies are developing 907 biologics targeting more than 100 diseases.

Report

Medicines in Development for Cancer 2015 Report

America’s biopharmaceutical research companies are developing 837 medicines and vaccines for cancer.

Report

Medicines in Development for Children 2012 Report

America’s biopharmaceutical companies are researching 316 medicines to help meet the unique health care needs of children and adolescents.

Report

Medicines in Development for COPD 2012 Report

America’s biopharmaceutical research companies are working on 54 medicines to treat COPD.

Report

Medicines in Development for Diabetes 2016 Report

America’s biopharmaceutical research companies are currently developing more than 170 innovative new medicines to help the more than 30 million Americans affected by diabetes.

Report

Medicines in Development for Heart Disease & Stroke 2015 Report

America’s biopharmaceutical research companies are developing 190 medicines for heart disease and stroke.

Report

Medicines in Development for HIV 2017 Report

America’s biopharmaceutical research companies are developing 52 medicines and vaccines for HIV.

Report

Medicines in Development for Immuno-Oncology 2017 Report

America’s biopharmaceutical research companies are developing more than 240 immuno-oncology treatments.

Report

Medicines in Development for Infectious Diseases 2013 Report

America’s biopharmaceutical companies are developing nearly 400 medicines and vaccines for infectious diseases.

Report

Medicines in Development for Leukemia & Lymphoma 2015 Report

America’s biopharmaceutical research companies are developing more than 240 medicines for leukemia and lymphoma.

Report

Medicines in Development for Mental Illnesses 2017 Report

America's biopharmaceutical research companies are developing more than 140 medicines for mental illnesses.

Report

Medicines in Development for Neurological Disorders 2015 Report

America's biopharmaceutical research companies are developing more than 400 medicines for neurological disorders.

Report

New Medicine Approvals 2015 Report

In 2015, the Food and Drug Administration (FDA) approved 57 new drugs and therapeutic biologics.

Report

Medicines in Development for Older Americans 2013 Report

America’s biopharmaceutical research companies currently are developing 435 innovative new medicines.

Report

Medicines in Development for Osteoporosis 2016 Report

America's biopharmaceutical research companies are developing nine medicines for the treatment of osteoporosis.

Report

Medicines in Development for Parkinson's Disease 2014 Report

America’s biopharmaceutical research companies are currently developing 37 medicines to help Americans living with Parkinson’s Disease.

Report

Medicines in Development for Rare Diseases 2016 Report

America's biopharmaceutical research companies are developing 566 medicines for patients with rare diseases.

Report

Medicines in Development for Skin Diseases 2011 Report

America's biopharmaceutical research companies are developing nearly 300 medicines to treat skin diseases.

Report

Medicines in Development for Vaccines 2016 Report

America's biopharmaceutical research companies are developing more than 250 vaccines.

Report

Medicines in Development for Women 2013 Report

America's biopharmaceutical research companies are developing 851 medicines for diseases that affect American women.